CopyMark Law Group
4.9/5
Drawing for BIODESK

USPTO serial 79290296

BIODESK

Reviewed by CopyMark Law Group

Reg. 6405781Status 700Renewal
Filing date
Status date
Registration date
Jul 6, 2021
Examiner
MESSICK, TABITHA LEE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIODESK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $325

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew P. Hintz, Esq.

Matthew P. Hintz, Esq. Lowenstein Sandler LLPOne Lowenstein DriveRoseland, NJ 07068United States

Goods and services

ClassDescriptionStatusFirst use
042Preparation of biostatistics for scientific research in the fields of pharmaceuticals, biotechnology and related industries; provision of information and data relating to medical and scientific research for pharmaceuticals, biotechnology and related industries; database design and development services to process data collected from clinical trials; product development; pharmaceutical drug development services; consultancy in the field of pharmacology; consultancy in the field of biotechnology; consultancy in the field of chemistry; consultancy relating to pharmaceutical research and development; medical and scientific research in the nature of preparation of reports and applications to regulators relating to aspects of clinical trials; providing a website featuring technology that allows an exchange of information between scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards; technical writing of clinical report forms which are required by clinical trial drug protocolsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 6, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 25, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 25, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 25, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 25, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 25, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 22, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 14, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 29, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 7, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 6, 2021FIMPFINAL DISPOSITION PROCESSED—
Oct 6, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 4, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jul 6, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 20, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 20, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 18, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 31, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 31, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 31, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 16, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 4, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 15, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 14, 2020RFRRREFUSAL PROCESSED BY MPU—
Aug 20, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 19, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2020DOCKASSIGNED TO EXAMINER—
Aug 4, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 31, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 31, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 30, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance